$百济神州(BGNE_老虎社区_美港股上老虎

$百济神州(BGNE)$ 五年来，百济神州的研发投入一直遥遥领先领先其他药企，2022年首次超过百亿人民币（110.34亿元）后，2023年再度增长至125.33亿元。

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":298749919072560,"tweetId":"298749919072560","gmtCreate":1713945707907,"gmtModify":1713946923346,"author":{"id":4129117073683340,"authorId":4129117073683340,"authorIdStr":"4129117073683340","name":"浮浮又沉沉","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><a target=\"_blank\" href=\"https://laohu8.com/S/BGNE\">$百济神州(BGNE)$ </a>五年来，百济神州的研发投入一直遥遥领先领先其他药企，2022年首次超过百亿人民币（110.34亿元）后，2023年再度增长至125.33亿元。\n<br></body></html>","htmlText":"<html><head></head><body><a target=\"_blank\" href=\"https://laohu8.com/S/BGNE\">$百济神州(BGNE)$ </a>五年来，百济神州的研发投入一直遥遥领先领先其他药企，2022年首次超过百亿人民币（110.34亿元）后，2023年再度增长至125.33亿元。\n<br></body></html>","text":"$百济神州(BGNE)$ 五年来，百济神州的研发投入一直遥遥领先领先其他药企，2022年首次超过百亿人民币（110.34亿元）后，2023年再度增长至125.33亿元。","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/298749919072560","repostId":0,"isVote":1,"tweetType":1,"viewCount":223,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["BGNE","688235","06160"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":132,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/298749919072560"}